Navigation Links
Video: Fortune 1000 Executives: New President Must Fix Education Gap
Date:9/17/2008

em, the Fortune executives say. Almost nine-in-10 (89 percent) agree that bringing more women and minorities into STEM fields will help solve this issue. Moreover, diversity has other benefits for STEM companies, according to the executives, including increasing innovation and the ability to be more competitive in the global marketplace.

Still, underrepresentation is prevalent. Nearly all of the executives are aware of this and many recognize underrepresentation for the talent problem it is. Almost nine-in-10 Fortune 1000 STEM executives (89 percent) acknowledge it exists in their industry, with a similar number (82 percent) reporting it exists in their own companies. Of those who say it is a reality for them, 83 percent say the lack of women, African Americans, Native Americans and Hispanics is a talent concern for their companies.

The Seed: Growing a Diverse American STEM Pipeline

Not surprisingly, almost all the senior executives (98 percent) say it is important for girls and minorities to receive a strong science and math education beginning in elementary school in order to reduce their underrepresentation in STEM fields, with nine-in-10 (90 percent) saying it is very important. And, say the executives, the most effective way for these students to learn science is through a hands-on, inquiry-based approach (87 percent).

However, they believe the U.S. education system is falling short here. Not one of the executives surveyed graded the U.S. an "A" when asked how good a job the U.S. pre-college system is doing in engaging and nurturing girls and minorities to pursue STEM careers. In fact, almost six-in-10 (55 percent) assigned it a failing grade of D or F.

The country's higher education system fares somewhat better for its ability to train women and minorities for STEM careers, with executives assigning it an average grade of "C+." Overall, the U.S. education system gets a "C" from executives for providing U.S. companies with div
'/>"/>

SOURCE Bayer Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Video: Keppra XR(TM) Approved in the U.S.
2. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
3. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
4. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
5. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
6. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
7. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
8. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
9. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
10. Online Systems Engineering Master's Program Attracts Engineers from Fortune 500 Firms
11. Quest Diagnostics Named to FORTUNE Magazines Americas Most Admired Companies List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2010)... at Philadelphia Conference , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced it will ... Bank and Cowen & Company at CBI,s 2010 Accounting and ... attended each year by over 300 finance, accounting, audit and ...
(Date:3/10/2010)... March 11 Thomson Reuters today announced it has ... Times Higher Education,s influential World University Rankings. The survey reflects ... resource to the global scholarly community. , ... ... ...
(Date:3/10/2010)... today announced the appointment of Mr. Kevin Giese , President, CEO and Director of BioMS Medical and Mr. Laine Woollard, QC , Senior Legal ... ... , ... ... ...
(Date:3/10/2010)... , ... ... ... , ... ...
Breaking Biology Technology:ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 2Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 3Spectral appoints two new board members 2Spectral appoints two new board members 3BR Ventures Invests in Semprae Laboratories 2BR Ventures Invests in Semprae Laboratories 3BR Ventures Invests in Semprae Laboratories 4
... Inc.,(Nasdaq: ONTY ) (TSX: ONY) (the "Company") ... in a Phase 1b clinical trial of PX-12 ... proprietary small molecule,inhibitor of thioredoxin, a protein that ... survival and drug resistance of,many cancers., The ...
... lecture and present a poster on proprietary siRNA ... targeting ... Quark Pharmaceuticals, Inc., a,development-stage pharmaceutical company discovering and developing ... the Cambridge Healthcare Institute,s 9th Annual Beyond,Genome Conference on ...
... DURECT Corporation,(Nasdaq: DRRX ) announced today that ... has been submitted to the U.S. Food,and Drug ... long,acting oral formulation of oxycodone intended to treat ... Remoxy is designed to resist,common methods of prescription ...
Other Biology Technology:Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 2Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 3Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 2Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 2New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 4New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 5
(Date:3/10/2010)... may eventually emerge as a lymphoma treatment, according to ... International Conference on Advances in Cancer Research: From the ... , Lymphoma is a cancer of the immune system ... are then further classified into B-cell and T-cell groups. ... resistant to standard treatment and thus new therapies are ...
(Date:3/10/2010)... Ala. Discovery of an antibiotic,s capacity to ... movement disorder researchers with leads to more desirable ... of Alabama scientists co-authoring a paper publishing March ... Mechanisms ., "It,s our hope that this ... clinical trial to evaluate the potential of drugs ...
(Date:3/10/2010)... Scientists have gained new insight into why a relatively ... hearing deficits, long after hearing is restored to normal. ... 11 issue of the journal Neuron , reveals ... auditory cortex is quite vulnerable if it does not ... , It is well established that degraded sensory experience ...
Breaking Biology News(10 mins):Movement disorder symptoms are lessened by an antibiotic 2Movement disorder symptoms are lessened by an antibiotic 3Research reveals that temporary hearing deprivation can lead to 'lazy ear' 2Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region 59508 1Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region 59508 2ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 1ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 2ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 3ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 4Healthcare Reform Activist Dr Lee Vliet Speaks Out on Healthcare Reform 59505 1Healthcare Reform Activist Dr Lee Vliet Speaks Out on Healthcare Reform 59505 2
... major cause of hospital-acquired infections can persist for ... in healthcare settings, including bed linens, computer keyboard ... today at the 105th General Meeting of the ... (MRSA) is a major cause of hospital-acquired infections ...
... of two critical proteins that normally shut down during ... the Cold Spring Harbor Laboratory have cured fruit flies ... same proteins-known in short form as CREB and HSP-70--exist ... study results, published online today by the Proceedings of ...
... University of Pittsburgh researchers first to report function of ... each other by an extensive network of tiny tunnels ... used to shoot signals to distant cells. This surprising ... of Medicine researchers in the September issue of the ...
Other Biology News:Huntington's cure in flies lays groundwork for broader treatment approaches 2'Underground' tunnels discovered as means for communication between immune system cells 2'Underground' tunnels discovered as means for communication between immune system cells 3'Underground' tunnels discovered as means for communication between immune system cells 4